| Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month … R Mody, Q Huang, M Yu, R Zhao, H Patel, M Grabner, LF Landó Diabetes, Obesity and Metabolism 21 (4), 920-929, 2019 | 83 | 2019 |
| Telephone-adapted Mindfulness-based Stress Reduction (tMBSR) for patients awaiting kidney transplantation CR Gross, M Reilly-Spong, T Park, R Zhao, OV Gurvich, HN Ibrahim Contemporary clinical trials 57, 37-43, 2017 | 65 | 2017 |
| Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies K Zhou, R Zhao, Z Geng, L Jiang, Y Cao, D Xu, Y Liu, L Huang, J Zhou Journal of thrombosis and thrombolysis 34 (4), 459-467, 2012 | 38 | 2012 |
| Inhibition of endoglin–GIPC interaction inhibits pancreatic cancer cell growth K Pal, AA Pletnev, SK Dutta, E Wang, R Zhao, A Baral, VK Yadav, ... Molecular cancer therapeutics 13 (10), 2264-2275, 2014 | 31 | 2014 |
| First-Line Immunotherapy Versus Targeted Therapy in Patients With BRAF-Mutant Advanced Melanoma: A Real-World Analysis AC Pavlick, R Zhao, CH Lee, C Ritchings, S Rao Future Oncology 17 (6), 689-699, 2021 | 27 | 2021 |
| Structural asymmetry of phosphodiesterase-9, potential protonation of a glutamic acid, and role of the invariant glutamine J Hou, J Xu, M Liu, R Zhao, HB Luo, H Ke PLoS One 6 (3), e18092, 2011 | 24 | 2011 |
| Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain JF Amacher, R Zhao, MR Spaller, DR Madden PloS one 9 (8), e103650, 2014 | 23 | 2014 |
| Impact of a limb salvage program on the economic burden of amputation in the United States S Palli, C Gunnarsson, H Kotlarz, BJ Martinsen, R Zhao, JA Rizzo Value in Health 19 (3), A45, 2016 | 22 | 2016 |
| Economic study design for the optimize study on orbital atherectomy and drug-coated balloon devices for the treatment of below-the-knee peripheral arterial disease BJ Martinsen, SA Weber, ML Pietzsch, A Behrens, M Weatherspoon, ... Value in Health 18 (7), A723, 2015 | 5 | 2015 |
| α-硫辛酸引起的胰岛素自身免疫综合征研究进展 周匡果， 赵睿智， 余学锋 临床内科杂志 28 (3), 211-214, 2011 | 4 | 2011 |
| Persistence and dose escalation during maintenance phase and use of nonbiologic medications among patients with ulcerative colitis initiated on ustekinumab in the United States M Zhdanava, R Zhao, AM Manceur, S Kachroo, P Lefebvre, D Pilon Crohn's & Colitis 360 5 (3), otad045, 2023 | 2 | 2023 |
| Sa1567: PERSISTENCE AND ADHERENCE AMONG PATIENTS WITH ULCERATIVE COLITIS INITIATED ON USTEKINUMAB D Pilon, R Zhao, AM Manceur, Z Ding, S Kachroo, M Vermette-Laforme, ... Gastroenterology 162 (7), S-417, 2022 | 2 | 2022 |
| Sa1562: PERSISTENCE AND DOSE TITRATION AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB OR: ADALIMUMAB D Pilon, Z Ding, AM Manceur, M Zhdanava, R Zhao, C Holiday, S Kachroo, ... Gastroenterology 162 (7), S-415, 2022 | 2 | 2022 |
| Prevalence and characteristics of patients receiving antifibrotic therapy for idiopathic pulmonary fibrosis Y Qiu, R Zhao, B Elpers, Y Wang, L Xie, J Tang, A Fischer European Respiratory Journal 56 (suppl 64), 2020 | 2 | 2020 |
| Dulaglutide has higher adherence and persistence than liraglutide and exenatide QW—one-year follow-up from US real-world data R MODY, Q HUANG, M YU, R ZHAO, H PATEL, M GRABNER, LF LANDO Diabetes 67 (Supplement_1), 2018 | 2 | 2018 |
| Comparative glycemic effectiveness of dulaglutide vs. liraglutide and exenatide QW in a US Real-world setting R Mody, Q Huang, M Yu, H Patel, R Zhao, M Grabner, LF Lando Diabetes 67 (Supplement_1), 2018 | 2 | 2018 |
| Patient factors affecting surgeon selection and the decision to delay total knee arthroplasty K Berend, R Zhao, A Carlson, M Stultz Reconstructive Review 7 (2), 2017 | 2 | 2017 |
| Long-term persistence and other treatment patterns among bio-naïve patients with Crohn’s disease treated with ustekinumab or adalimumab M Zhdanava, Z Ding, AM Manceur, R Zhao, C Holiday, S Kachroo, ... Current Medical Research and Opinion 39 (9), 1215-1225, 2023 | 1 | 2023 |
| Persistence and other treatment patterns among bio-experienced patients with Crohn’s disease initiated on ustekinumab or adalimumab M Zhdanava, R Zhao, AM Manceur, Z Ding, S Kachroo, C Holiday, ... Journal of Managed Care & Specialty Pharmacy 29 (8), 907-916, 2023 | 1 | 2023 |
| Real-world ustekinumab persistence in patients with ulcerative colitis attaining the maintenance phase M Zhdanava, S Kachroo, A Shah, Z Ding, C Holiday, P Lefebvre, R Zhao, ... Gastroenterology 164 (4), S46-S47, 2023 | 1 | 2023 |
